Penguin Ai

Based in the US, Penguin Ai provides an innovative AI platform that streamlines healthcare administrative workflows, aiming to reduce inefficiencies in the sector. Penguin Ai, founded in 2024 and headquartered in Palo Alto, US, specializes in an AI-driven healthcare platform that addresses administrative waste in the healthcare sector. The company has secured Series A funding of USD 25 million in September 2025, primarily led by Greycroft Partners, with participation from several other investors. With a total of 2 deals to date, the company continues to expand its operational capabilities under the leadership of its founder, whose previous ventures are not disclosed.

Penguin Ai focuses on an advanced healthcare artificial intelligence platform that targets the estimated USD 1 trillion in administrative waste in healthcare. The platform features integrated solutions that enhance healthcare workflows by automating processes in prior authorization, billing, claims adjudication, medical coding, and denials management. Utilizing a healthcare-native Small Language Model, the platform improves efficiency and accuracy for healthcare payers and providers without requiring changes to existing systems, catering primarily to clients in the US but with potential global applications. Penguin Ai operates on a subscription-based revenue model, partnering with healthcare institutions, including providers and payers.

Customers access various functionalities of the platform through tiered pricing plans based on the services they utilize, such as automated prior authorization or claims processing. While precise pricing details are not disclosed, the platform's structure aims to deliver a rapid return on investment, reportedly within 90 days, by reducing administrative costs and enhancing operational efficiency for client organizations . Following its recent Series A funding round of USD 25 million, closed on September 11, 2025, Penguin Ai plans to utilize these resources to accelerate product development and expand its operations. The company is focused on launching new products that improve healthcare administrative processes, while also exploring expansion into additional markets beyond the United States.

The funding will support these initiatives and bolster product deployments, enhancing the company's growth trajectory.